Advancements in Radiomics and Artificial Intelligence for Thyroid Cancer Diagnosis

TL;DR

This review discusses recent advances in AI and radiomics for thyroid cancer diagnosis, highlighting their potential, challenges, and future directions to improve diagnostic accuracy and patient outcomes.

Contribution

It provides a comprehensive synthesis of recent studies on AI and radiomics in thyroid cancer diagnosis, emphasizing challenges and proposing future research directions.

Findings

Radiomics with ultrasound images effectively diagnoses thyroid cancer.

Some new AI strategies outperform existing methods.

Challenges include interpretability, dataset limitations, and operator dependence.

Abstract

Thyroid cancer is an increasing global health concern that requires advanced diagnostic methods. The application of AI and radiomics to thyroid cancer diagnosis is examined in this review. A review of multiple databases was conducted in compliance with PRISMA guidelines until October 2023. A combination of keywords led to the discovery of an English academic publication on thyroid cancer and related subjects. 267 papers were returned from the original search after 109 duplicates were removed. Relevant studies were selected according to predetermined criteria after 124 articles were eliminated based on an examination of their abstract and title. After the comprehensive analysis, an additional six studies were excluded. Among the 28 included studies, radiomics analysis, which incorporates ultrasound (US) images, demonstrated its effectiveness in diagnosing thyroid cancer. Various results were noted, some of the studies presenting new strategies that outperformed the status quo. The literature has emphasized various challenges faced by AI models, including interpretability issues, dataset constraints, and operator dependence. The synthesized findings of the 28 included studies mentioned the need for standardization efforts and prospective multicenter studies to address these concerns. Furthermore, approaches to overcome these obstacles were identified, such as advances in explainable AI technology and personalized medicine techniques. The review focuses on how AI and radiomics could transform the diagnosis and treatment of thyroid cancer. Despite challenges, future research on multidisciplinary cooperation, clinical applicability validation, and algorithm improvement holds the potential to improve patient outcomes and diagnostic precision in the treatment of thyroid cancer.